current treatment modalities for epidermal growth factor egfrpositive cancers have recently included the use of antibodies and smallmolecule tyrosinekinase inhibitors tkia significant limiting step in the use of these agents is dermatological toxicity frequently in the form of an acneiform eruptionpresent management modalities for this toxicity are largely ineffectivecolloidal oatmeal lotion demonstrates multiple antiinflammatory properties with known effects on arachidonic acid cytosolic phospholipase a2 and tumour necrosis factoralpha pathways along with an excellent sideeffect profiletreatment with colloidal oatmeal was applied to 11 patients with a rash induced by cetuximab erlotinib panitumumab and sorafenibof the 10 assessable patients 6 had complete response and 4 partial response giving a response rate of 100 with no associated toxicitiestreatment with colloidal oatmeal lotion is efficient in controlling the rash associated with egfr and multiple tki and allows continuation of the antineoplastic treatment